New insight in to the SAR of pyrimido [4,5-b] [1,4] benzothiazines as 15-lipoxygenase inhibitors

Iranian Journal of Basic Medical Sciences

Volumn 16, Issue 6, 2013, Pages 784-789

  Pooryaghoobi, Nona ^a   Bakavoli, Mehdi ^b   Alimardani, Maliheh ^c   Bazzazan, Tahmineh ^b   Sadeghian, Hamid ^c,d  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

^b FERDOWSI UNIVERSITY OF MASHHAD   (Iran)

^c MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

DMAB; Docking; MBTH; Peroxide formation; SLO

Indexed keywords

ARACHIDONATE 15 LIPOXYGENASE; LIPOXYGENASE INHIBITOR; PYRIMIDO[4,5 B][L,4]BENZOTHIAZINE; UNCLASSIFIED DRUG;

ARTICLE; COMPARATIVE STUDY; MOLECULAR DOCKING; SOYBEAN; SPECTROPHOTOMETRY; STRUCTURE ACTIVITY RELATION;

EID: 84880269481     PISSN: 20083866     EISSN: 20083874     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Brash AR. Lipoxygenases: Occurrence, functions, catalysis, and acquisition of substrate. J Biol Chem 1999; 274:23679-23682.
2. Kuhn H, Thiele BJ. The diversity of the lipoxygenase family. Many sequence data but little information on biological significance. FEBS Lett 1999; 449:7-11.
3. Larsen JS, Acosta EP. Leukotriene-receptor antagonists and 5-lipoxygenase inhibitors in asthma. Ann Pharmacother 1993; 27:898-903.
4. Schewe T. 15-Lipoxygenase-1: a prooxidant enzyme. Biol Chem 2002; 383:365-374.
5. Kelavkar U, Glasgow W, Eling TE. The effect of 15-lipoxygenase-1 expression on cancer cells. Curr Urol Rep 2002; 3:207-214.
6. Kelavkar UP, Cohen C, Kamitani H, Eling TE, Badr KF. Concordant induction of 15-lipoxygenase-1 and mutant p53 expression in human prostate adenocarcinoma: correlation with Gleason staging. Carcinogenesis 2000; 21:1777-1787.
7. Zhu J, Kilty I, Granger H, Gamble E, Qiu YS, Hattotuwa K, et al. Gene expression and immunolocalization of 15-lipoxygenase isozymes in the airway mucosa of smokers with chronic bronchitis. Am J Respir Cell Mol Biol 2002; 27:666-677.
8. Zhao L, Funk CD. Lipoxygenase pathways in atherogenesis. Trends Cardiovasc Med 2004; 14:191-195.
9. Cyrus T, Witztum JL, Rader DJ, Tangirala R, Fazio S, Linton MF, Funk CD, et al. Distruption of the12/15-Lipoxygenase gene diminishes atherosclerosis in Apo E-deficient mice. J Clin Invest 1999; 103:1597-1604.
10. Harats D, Shaish A, George J, Mulkins M, Kurihara H, Levkovitz H, et al. Overexpression of 15-Lipoxygenase in vascular endothelium accelerates early atherosclerosis in LDL reseptor-deficient mice. Arterioscler Thromb Vasc Biol 2002; 20:2100-2105.
11. Sultana C, Shen Y, Rattan V. Lipoxygenase metabolites induced expression of adhesion molecules and transendothelial migration of monocyte-like HL-60 cells is linked to protein kinase C activation. Cell Phys 1996; 167:477-487.
12. Setty BN, Werner MH, Annun YA, Stuart MJ. 15-hydroxyeicosatetraenoic acid -mediated potentiation of thrombin-induced platelet functions occurs via enhanced production of phosphoinositide-derived second messengers 1,2-diacylglycerol and inositol-1,4,5-trisphosphate. Blood 1992; 80: 2765-2773.
13. Charlier C, Michaux C, Dual inhibition of cyclooxygenase-2 (COX-2) and 5-Lipoxygenase (5-LOX) as a new start to provide safer non-steroidal anti-inflammatory drugs. Eur J Med Chem 2003; 38:645-659.
14. Bakavoli M, Nikpour M, Rahimizadeh M, Saberi MR, Sadeghian H. Design and synthesis of pyrimido[4,5-e][1,3,4] thiadiazine derivatives as potent 15-Lipoxygenase inhibitors. Bioorg Med Chem 2007; 15:2120-2126.
15. Bakavoli M, Sadeghian H, Tabatabaei Z, Rahimizadeh M, Nikpour M. SAR comparative studies on pyrimido[4,5-b][1,4]benzothiazine derivatives as 15- Lipoxygenase inhibitors using ab initio calculations. J Mol Model 2008; 14:471-476.
16. Jabbari A, Davoodnejad M, Alimardani M, Assadieskandar A, Sadeghian A, Safdari H, et al. Synthesis and SAR Studies of 3-Allyl-4-prenyloxyaniline Amides as Potent 15-Lipoxygenase Inhibitors. Bioorg Med Chem 2012; 20:5518-5526.
17. Caballero J, Fernandez M, Coll D. Quantitative structure-activity relationship of organosulphur compounds as soybean 15-lipoxygenase inhibitors using CoMFA and CoMSIA. Chem Biol Drug Des 2010; 76:511-517.
18. Sadeghian H, Seyedi SM, Saberi MR, Arghiani Z. Design and synthesise of eugenol derivatives, as potent 15- Lipoxygenase inhibitors. Bioorg Med Chem 2008; 16:890-901.
19. Sadeghian H, Attaran N, Jafari Z, Saberi MR, Pordel M, Riazi M, Design and synthesis of 4-methoxyphenylacetic acid esters as 15-lipoxygenase inhibitors and SAR comparative studies of them. Bioorg Med Chem 2009; 17:2327-2335.
20. ChemDraw® Ultra, Chemical Structure Drawing Standard, Cambridge Soft Corporation, 100 Cambridge Park Drive, Cambridge, MA 02140 USA. Available at: http://www.Cambridgesoft.com
21. HyperChem® Release 7, Hypercube Inc. Available at: http://www.hyper.com/
22. Auto Dock Tools (ADT), the Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037-1000, USA. Available at:http://www.scripps.edu/pub/olson-web/doc/autodock/.
23. Morris GM, Goodsell DS, Halliday RS, Huey R, Hart WE, Belew RK, et al. Automated Docking using a Lamarckian Genetic Algorithm and an Empirical binding free energy function. J Comput Chem 1998; 19:1639-1662.
24. Sippl WJ. Receptor-based 3D QSAR analysis of estrogen receptor ligands-merging the accuracy of receptor-based alignments with the computational efficiency of ligand-based methods. J Comput Aided Mol Des 2000; 14:559-572.
25. Iranshahi M, Jabbari A, Orafaie A, Mehri R, Zeraatkar S, Ahmadi T, Alimardani M, Sadeghian H, Synthesis and SAR studies of mono O-prenylated coumarins as potent 15-lipoxygenase inhibitors. Eur J Med Chem 2012; 57:134-142.
26. Huey R, Morris GM. Auto Dock Tools; A Tutorial, 2006, 10550 North Torrey pines Road, CA92037-1000, USA.
27. http://www.accelrys.com/products/discovery-studio